OTCMKTS:SLFPY abrdn (SLFPY) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free SLFPY Stock Alerts $7.03 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$7.03▼$7.0350-Day Range$6.71▼$8.1852-Week Range$6.71▼$12.15Volume31 shsAverage Volume432 shsMarket Capitalization$3.24 billionP/E RatioN/ADividend Yield9.10%Price TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort Interest Get abrdn alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About abrdn Stock (OTCMKTS:SLFPY)abrdn plc provides asset management services in the United Kingdom, Europe, North America, and Asia. The company offers investment solutions and funds; long-term savings and investment products to individual and corporate customers; and life insurance and savings products. It provides its products through institutional, wholesale, and retail distribution channels. It also makes real estate investments. The company was formerly known as Standard Life Aberdeen plc. abrdn plc was founded in 1825 and is headquartered in Edinburgh, United Kingdom.Read More SLFPY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SLFPY Stock News HeadlinesApril 16, 2024 | lse.co.ukAbrdn Great Share ChatNovember 23, 2023 | finance.yahoo.comabrdn plc (LON:ABDN) most popular amongst individual investors who own 52% of the shares, institutions hold 46%April 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!November 10, 2023 | uk.investing.comAbrdn PLC DRC (SLFPY)October 31, 2023 | morningstar.comabrdn PLC ABDNOctober 12, 2023 | lse.co.ukAbrdn Japan B Share ChatOctober 12, 2023 | finance.yahoo.comEven after rising 8.4% this past week, abrdn (LON:ABDN) shareholders are still down 7.6% over the past five yearsAugust 16, 2023 | msn.comabrdn plc goes ex dividend tomorrowApril 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!July 11, 2023 | financialpost.comFidelity, Abrdn Hunt Industries Seen Immune to China SlowdownJune 9, 2023 | morningstar.comabrdn Total Dynamic Dividend AODJune 6, 2023 | finance.yahoo.comSLFPY - abrdn plcJune 5, 2023 | markets.businessinsider.comAbrdn Commences Up To £150 Mln Repurchase ProgrammeMay 27, 2023 | seekingalpha.comBCI abrdn Bloomberg All Commodity Strategy K-1 Free ETFApril 21, 2023 | benzinga.comabrdn Inc Credit Strat Stock (NYSE:ACP), DividendsFebruary 22, 2023 | seekingalpha.comACP.PA abrdn Income Credit Strategies Fund 5.250% Series A Perpetual Preferred StockFebruary 11, 2023 | morningstar.comabrdn Intmdt Muncpl Inc InstlJanuary 27, 2023 | morningstar.comabrdn Emerging Mkts SustLdrs InstlSvcJanuary 25, 2023 | morningstar.comabrdn US Sustainable Leaders InstlSvcJanuary 22, 2023 | morningstar.comabrdn Global Equity Impact ASeptember 9, 2022 | seekingalpha.comUK Top 40 High-Yield Blue-Chip Stocks: Q3 2022July 2, 2022 | seekingalpha.comLatest Stock AnalysisMay 27, 2022 | finance.yahoo.comDefault Threat Reaches Pakistan as Political Crisis DeepensMarch 1, 2022 | nasdaq.comAbrdn Plc FY21 Profit Climbs; Maintains Dividend, Outlook; Stock DownMarch 1, 2022 | finance.yahoo.comUK fund manager Abrdn rules out Russia investment for ‘foreseeable future’February 20, 2022 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of abrdn plc (LON:ABDN) Shares?February 13, 2022 | finance.yahoo.comStocks Decline, Crude Rallies Amid Ukraine Tension: Markets WrapSee More Headlines Receive SLFPY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for abrdn and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/15 Dividend3/14/2024Today4/25/2024Dividend Payable5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:SLFPY CUSIPN/A CIK1370418 Webwww.standardlifeaberdeen.com Phone441312252552FaxN/AEmployees5,299Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.74 billion Price / Sales1.86 Cash Flow$0.56 per share Price / Cash Flow12.58 Book Value$14.52 per share Price / Book0.48Miscellaneous Outstanding Shares460,180,000Free FloatN/AMarket Cap$3.24 billion OptionableNot Optionable Beta1.51 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Stephen Bird MBA (Age 57)CEO & Director Comp: $2.3MMr. Jason Michael Windsor (Age 52)CFO & Director Comp: $977.47kMr. Michael Tumilty (Age 53)Global Chief Operating Officer Mr. Rene BuehlmannChief Executive Officer of InvestmentsMr. Mark DixonCTO & Chief Information OfficerMs. Sarah MoodyChief Corporate Affairs & Investor Relations OfficerMr. Rushad Abadan (Age 51)Group General Counsel Barry KaneHead of Regulatory Risk & ComplianceMr. Jean GuaySenior Vice President of Sales & MarketingMs. Tracey HahnChief People OfficerMore ExecutivesKey CompetitorsBank of East AsiaOTCMKTS:BKEAYSmartCentres Real Estate Investment TrustOTCMKTS:CWYUFDerwent LondonOTCMKTS:DWVYFShizuoka Financial Group,Inc.OTCMKTS:SHZUYHOPEWELL HOLDIN/ADROTCMKTS:HOWWYView All Competitors SLFPY Stock Analysis - Frequently Asked Questions How have SLFPY shares performed in 2024? abrdn's stock was trading at $9.03 at the start of the year. Since then, SLFPY shares have decreased by 22.1% and is now trading at $7.03. View the best growth stocks for 2024 here. How often does abrdn pay dividends? What is the dividend yield for abrdn? abrdn declared a dividend on Thursday, February 29th. Shareholders of record on Friday, March 15th will be paid a dividend of $0.3203 per share on Wednesday, May 15th. The ex-dividend date is Thursday, March 14th. Read our dividend analysis for SLFPY. Is abrdn a good dividend stock? abrdn (OTCMKTS:SLFPY) pays an annual dividend of $0.64 per share and currently has a dividend yield of 9.41%. SLFPY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for SLFPY. How do I buy shares of abrdn? Shares of SLFPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SLFPY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.